108 related articles for article (PubMed ID: 26086753)
1. Phase I/II Gene Therapy Trial of Fanconi Anemia Patients with a New Orphan Drug Consisting of a Lentiviral Vector Carrying the FANCA Gene: A Coordinated International Action (EuroFancolen).
Hum Gene Ther Clin Dev; 2015 Jun; 26(2):81-2. PubMed ID: 26086753
[No Abstract] [Full Text] [Related]
2. Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.
Molina-Estevez FJ; Nowrouzi A; Lozano ML; Galy A; Charrier S; von Kalle C; Guenechea G; Bueren JA; Schmidt M
Curr Gene Ther; 2015; 15(6):550-62. PubMed ID: 26415575
[TBL] [Abstract][Full Text] [Related]
3. Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.
Becker PS; Taylor JA; Trobridge GD; Zhao X; Beard BC; Chien S; Adair J; Kohn DB; Wagner JE; Shimamura A; Kiem HP
Gene Ther; 2010 Oct; 17(10):1244-52. PubMed ID: 20485382
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
[TBL] [Abstract][Full Text] [Related]
5. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
Müller LU; Milsom MD; Kim MO; Schambach A; Schuesler T; Williams DA
Mol Ther; 2008 Jun; 16(6):1154-60. PubMed ID: 18398427
[TBL] [Abstract][Full Text] [Related]
6. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
[TBL] [Abstract][Full Text] [Related]
7. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
8. AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice.
Pulliam AC; Hobson MJ; Ciccone SL; Li Y; Chen S; Srour EF; Yang FC; Broxmeyer HE; Clapp DW
Exp Hematol; 2008 Sep; 36(9):1084-90. PubMed ID: 18495331
[TBL] [Abstract][Full Text] [Related]
9. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
[TBL] [Abstract][Full Text] [Related]
11. Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice.
Si Y; Ciccone S; Yang FC; Yuan J; Zeng D; Chen S; van de Vrugt HJ; Critser J; Arwert F; Haneline LS; Clapp DW
Blood; 2006 Dec; 108(13):4283-7. PubMed ID: 16946306
[TBL] [Abstract][Full Text] [Related]
12. Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector.
Yamada K; Ramezani A; Hawley RG; Ebell W; Arwert F; Arnold LW; Walsh CE
Mol Ther; 2003 Oct; 8(4):600-10. PubMed ID: 14529833
[TBL] [Abstract][Full Text] [Related]
13. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
[TBL] [Abstract][Full Text] [Related]
14. Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766.
Milsom MD; Lee AW; Zheng Y; Cancelas JA
Haematologica; 2009 Jul; 94(7):1011-5. PubMed ID: 19491337
[TBL] [Abstract][Full Text] [Related]
15. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34
Río P; Navarro S; Guenechea G; Sánchez-Domínguez R; Lamana ML; Yañez R; Casado JA; Mehta PA; Pujol MR; Surrallés J; Charrier S; Galy A; Segovia JC; Díaz de Heredia C; Sevilla J; Bueren JA
Blood; 2017 Sep; 130(13):1535-1542. PubMed ID: 28801449
[TBL] [Abstract][Full Text] [Related]
16. KIT blockade is sufficient for donor hematopoietic stem cell engraftment in Fanconi anemia mice.
Chandrakasan S; Jayavaradhan R; Ernst J; Shrestha A; Loberg A; Dexheimer P; Jordan M; Pang Q; Aronow B; Malik P
Blood; 2017 Feb; 129(8):1048-1052. PubMed ID: 27998889
[No Abstract] [Full Text] [Related]
17. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
18. Targeted gene therapy and cell reprogramming in Fanconi anemia.
Rio P; Baños R; Lombardo A; Quintana-Bustamante O; Alvarez L; Garate Z; Genovese P; Almarza E; Valeri A; Díez B; Navarro S; Torres Y; Trujillo JP; Murillas R; Segovia JC; Samper E; Surralles J; Gregory PD; Holmes MC; Naldini L; Bueren JA
EMBO Mol Med; 2014 Jun; 6(6):835-48. PubMed ID: 24859981
[TBL] [Abstract][Full Text] [Related]
19. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
20. Anchored Lentiviral Vector Episomes for Stem Cell Gene Therapy in Fanconi Anemia.
Verghese SC; Kurre P
Curr Gene Ther; 2017; 16(5):329-337. PubMed ID: 28093967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
